ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD.

The company takes the cause of human health as its mission, and is committed to providing high-quality medical and health products to patients around the world, continuously improving the accessibility of products and improving the quality of life of the public. The company was founded in 1989 and is headquartered in Zhejiang, China. The business covers various fields such as chemicals, biopharmaceuticals, pharmaceutical packaging, and trade circulation. The company is mainly engaged in R&D, production and sales of multi-dosage generic drugs, biopharmaceuticals, innovative drugs and specialty APIs. The main products are irbesartan hydrochlorothiazide tablets, losartan potassium tablets, valsartan amlodipine tablets, valsartan hydrochlorothiazide tablets, paroxetine hydrochloride tablets, donepezil hydrochloride tablets, levetiracetam tablets, escitalopram oxalate tablets, dobashydrazide tablets, oseltamivir phosphate capsules, voriconazole tablets, rivaroxaban tablets, esomeprazole magnesium enteric capsules, methopepib citrate tablets for injection Trexate disodium, febusta tablets, etc. Company Honors: National Industry-Education Integrated Enterprise, National Key High-tech Enterprise, National Innovative Enterprise, National Technological Innovation Demonstration Enterprise.